Abstract
Pancreatic adenocarcinoma is one of the oncological disease with the markedly poor prognosis. A searching of the new treatment options are desirable to improve this fact.
Only a radical resection of tumor is a chance of long-term survival. A possible procedure leads to this point is neoadjuvant treatment.
There was a series of clinical trial that evaluated its efficacy.